Japan’s Takeda Pharma says full-year profit slid 9.5%
15:24 JST, May 11, 2022
TOKYO (Reuters) – Takeda Pharmaceutical Co said on Wednesday that 12-month operating profit slid 9.5% from the previous year.
Operating profit for Japan’s largest drugmaker in the year that ended on March 31 came in at 461 billion yen ($3.54 billion).
That compares with its own earlier estimate of 515 billion yen and a consensus forecast of 509 billion yen from a Refinitiv poll of 15 analysts.
The company estimated the current fiscal year’s operating profit will rise to 520 billion yen.
($1 = 130.3700 yen)
"News Services" POPULAR ARTICLE
-
Dollar Edges Lower, Yen at 34-year Trough
-
Japan’s Nikkei Climbs 1.5% as Investors Scoop Up Beaten-Down Stocks (Update 1)
-
Japan Visitors Exceed 3 Mln in March, a Monthly Record, Tourism Agency Says
-
EU Ratchets up Pressure on TikTok’s New Rewards App over Risks to Kids, Warns of Suspension
-
Japan’s Nikkei Ends 1% Higher after Sharp Fall; Chip-Related Shares Weigh (Update 1)
JN ACCESS RANKING
- Japan Household Spending Down 0.5% in Feb.
- China Mutes Memorialization of Reformer Hu Yaobang; Memories Could Spark Critique of Xi Administration
- Shinkansen Services Suspended After Man ‘Searches for Phone’ on Tracks; Disruption Affects About 14,000 Passengers
- U.S. 7th Fleet officer Arrested on Suspicion of Stealing Sushi, Sashimi, Chicken at Kanagawa Shopping Mall; Suspect Caught Mid-Meal
- UNRWA Director Describes Catastrophic Destruction in Gaza; Says Relief Trucks Robbed, ‘People’s Hearts Destroyed’